{"id":1165,"date":"2014-01-15T09:31:28","date_gmt":"2014-01-15T08:31:28","guid":{"rendered":"https:\/\/www.aica3.org\/cms\/?p=1165"},"modified":"2022-01-06T09:47:55","modified_gmt":"2022-01-06T08:47:55","slug":"farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr","status":"publish","type":"post","link":"https:\/\/www.aica3.org\/cms\/en\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/","title":{"rendered":"Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients."},"content":{"rendered":"<p><em>D&#8217;Angelo MG, Gandossini S, Martinelli Boneschi F, Sciorati C, Bonato S, Brighina E, Comi GP, Turconi AC, Magri F, Stefanoni G, Brunelli S, Bresolin N, Cattaneo D, Clementi E.<br \/>\nPharmacol Res 2012 Apr;65(4):472-9.<\/em><\/p>\n<p class=\"translation-block\"><strong>Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients.<\/strong><br>\nThis open-label, single centre pilot study was designed to evaluate safety and tolerability of the combination of the drugs isosorbide dinitrate, a nitric oxide donor, and ibuprofen, a non steroid anti-inflammatory drug, in a cohort of adult dystrophic patients (Duchenne, Becker and Limb-Girdle Muscular Dystrophy). Seventy-one patients were recruited: 35, treated with the drug combination for 12 months, and 36 untreated. Safety and adverse events were assessed by reported signs and symptoms, physical examinations, blood tests, cardiac and respiratory function tests. Exploratory outcomes measure, such as the motor function measure scale, were also applied. Good safety and tolerability profiles of the long-term co-administration of the drugs were demonstrated. Few and transient side effects (i.e. headache and low blood pressure) were reported. Additionally, exploratory outcomes measures were feasible in all the disease population studied and evidenced a trend towards amelioration that reached statistical significance in one dimension of the MFM scale. Systemic administration of ibuprofen and isosorbide dinitrate provides an adequate safety margin for clinical studies aimed at assessing efficacy.<\/p>\n<p><a href=\"https:\/\/www.aica3.org\/cms\/wp-content\/uploads\/2014\/01\/5.dangelo2012.pdf\" target=\"_blank\" rel=\"noopener\">Click to download the full version of the article<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>D&#8217;Angelo MG, Gandossini S, Martinelli Boneschi F, Sciorati C, Bonato S, Brighina E, Comi GP, Turconi AC, Magri F, Stefanoni G, Brunelli S, Bresolin N, Cattaneo D, Clementi E. Pharmacol Res 2012 Apr;65(4):472-9. Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[34,33],"tags":[],"class_list":["post-1165","post","type-post","status-publish","format-standard","hentry","category-articoli-scientifici","category-ricerca-e-pubblicazioni"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con misure di efficacia esplorative in pazienti distrofici adulti. - AICa3 - ETS - Associazione Italiana Calpaina 3<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aica3.org\/cms\/en\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con misure di efficacia esplorative in pazienti distrofici adulti. - AICa3 - ETS - Associazione Italiana Calpaina 3\" \/>\n<meta property=\"og:description\" content=\"D&#8217;Angelo MG, Gandossini S, Martinelli Boneschi F, Sciorati C, Bonato S, Brighina E, Comi GP, Turconi AC, Magri F, Stefanoni G, Brunelli S, Bresolin N, Cattaneo D, Clementi E. Pharmacol Res 2012 Apr;65(4):472-9. Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aica3.org\/cms\/en\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/\" \/>\n<meta property=\"og:site_name\" content=\"AICa3 - ETS - Associazione Italiana Calpaina 3\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/pages\/AICa3-Associazione-Italiana-Calpaina-3\/119599211561350\" \/>\n<meta property=\"article:published_time\" content=\"2014-01-15T08:31:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-06T08:47:55+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/#\\\/schema\\\/person\\\/8a5e19b3ab1d1aa2190043f3ddb89aa2\"},\"headline\":\"Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con misure di efficacia esplorative in pazienti distrofici adulti.\",\"datePublished\":\"2014-01-15T08:31:28+00:00\",\"dateModified\":\"2022-01-06T08:47:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\\\/\"},\"wordCount\":302,\"articleSection\":[\"Articoli scientifici\",\"Ricerca e Pubblicazioni\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\\\/\",\"url\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\\\/\",\"name\":\"Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con misure di efficacia esplorative in pazienti distrofici adulti. - AICa3 - ETS - Associazione Italiana Calpaina 3\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/#website\"},\"datePublished\":\"2014-01-15T08:31:28+00:00\",\"dateModified\":\"2022-01-06T08:47:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/#\\\/schema\\\/person\\\/8a5e19b3ab1d1aa2190043f3ddb89aa2\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.aica3.org\\\/cms\\\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con misure di efficacia esplorative in pazienti distrofici adulti.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/#website\",\"url\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/\",\"name\":\"AICa3 - ETS - Associazione Italiana Calpaina 3\",\"description\":\"Sito ufficiale dell\u2019Associazione Italiana Calpaina 3 per la lotta alla Distrofia Muscolare dei cingoli da deficit di Calpaina 3.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/#\\\/schema\\\/person\\\/8a5e19b3ab1d1aa2190043f3ddb89aa2\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/www.aica3.org\\\/cms\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con misure di efficacia esplorative in pazienti distrofici adulti. - AICa3 - ETS - Associazione Italiana Calpaina 3","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aica3.org\/cms\/en\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/","og_locale":"en_GB","og_type":"article","og_title":"Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con misure di efficacia esplorative in pazienti distrofici adulti. - AICa3 - ETS - Associazione Italiana Calpaina 3","og_description":"D&#8217;Angelo MG, Gandossini S, Martinelli Boneschi F, Sciorati C, Bonato S, Brighina E, Comi GP, Turconi AC, Magri F, Stefanoni G, Brunelli S, Bresolin N, Cattaneo D, Clementi E. Pharmacol Res 2012 Apr;65(4):472-9. Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con [&hellip;]","og_url":"https:\/\/www.aica3.org\/cms\/en\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/","og_site_name":"AICa3 - ETS - Associazione Italiana Calpaina 3","article_publisher":"http:\/\/www.facebook.com\/pages\/AICa3-Associazione-Italiana-Calpaina-3\/119599211561350","article_published_time":"2014-01-15T08:31:28+00:00","article_modified_time":"2022-01-06T08:47:55+00:00","author":"admin","twitter_misc":{"Written by":"admin","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.aica3.org\/cms\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/#article","isPartOf":{"@id":"https:\/\/www.aica3.org\/cms\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/"},"author":{"name":"admin","@id":"https:\/\/www.aica3.org\/cms\/#\/schema\/person\/8a5e19b3ab1d1aa2190043f3ddb89aa2"},"headline":"Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con misure di efficacia esplorative in pazienti distrofici adulti.","datePublished":"2014-01-15T08:31:28+00:00","dateModified":"2022-01-06T08:47:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.aica3.org\/cms\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/"},"wordCount":302,"articleSection":["Articoli scientifici","Ricerca e Pubblicazioni"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.aica3.org\/cms\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/","url":"https:\/\/www.aica3.org\/cms\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/","name":"Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con misure di efficacia esplorative in pazienti distrofici adulti. - AICa3 - ETS - Associazione Italiana Calpaina 3","isPartOf":{"@id":"https:\/\/www.aica3.org\/cms\/#website"},"datePublished":"2014-01-15T08:31:28+00:00","dateModified":"2022-01-06T08:47:55+00:00","author":{"@id":"https:\/\/www.aica3.org\/cms\/#\/schema\/person\/8a5e19b3ab1d1aa2190043f3ddb89aa2"},"breadcrumb":{"@id":"https:\/\/www.aica3.org\/cms\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aica3.org\/cms\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.aica3.org\/cms\/farmaci-donatori-di-ossido-nitrico-ed-anti-infiammatori-non-steroidei-come-terapia-per-le-distrofie-muscolari-evidenze-da-uno-studio-di-sicurezza-con-misure-di-efficacia-esplorative-in-pazienti-distr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.aica3.org\/cms\/"},{"@type":"ListItem","position":2,"name":"Farmaci donatori di ossido nitrico ed anti-infiammatori non steroidei come terapia per le distrofie muscolari: evidenze da uno studio di sicurezza con misure di efficacia esplorative in pazienti distrofici adulti."}]},{"@type":"WebSite","@id":"https:\/\/www.aica3.org\/cms\/#website","url":"https:\/\/www.aica3.org\/cms\/","name":"AICa3 - ETS - Associazione Italiana Calpaina 3","description":"Sito ufficiale dell\u2019Associazione Italiana Calpaina 3 per la lotta alla Distrofia Muscolare dei cingoli da deficit di Calpaina 3.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aica3.org\/cms\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.aica3.org\/cms\/#\/schema\/person\/8a5e19b3ab1d1aa2190043f3ddb89aa2","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4b904785971eb1f4a705b7613434a976e92728da57cacd525748a7d680e4cccc?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.aica3.org\/cms\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.aica3.org\/cms\/en\/wp-json\/wp\/v2\/posts\/1165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aica3.org\/cms\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aica3.org\/cms\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aica3.org\/cms\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aica3.org\/cms\/en\/wp-json\/wp\/v2\/comments?post=1165"}],"version-history":[{"count":0,"href":"https:\/\/www.aica3.org\/cms\/en\/wp-json\/wp\/v2\/posts\/1165\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.aica3.org\/cms\/en\/wp-json\/wp\/v2\/media?parent=1165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aica3.org\/cms\/en\/wp-json\/wp\/v2\/categories?post=1165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aica3.org\/cms\/en\/wp-json\/wp\/v2\/tags?post=1165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}